Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q3 2013 · 10-Q
Revenue$0.00$0.00— vs Q3 2012 Net Income-$950.06K-$950.06KN/M vs Q3 2012 EPS Diluted$0.00$0.00— vs Q3 2012 Operating Income-$940,881N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 19, 2013 · 50 d after period end